All News

The Science4Refugees initiative aims to help refugee researchers find jobs and training in research institutes

With the EU’s highest court striking down the 15-year old agreement that allowed companies to store the personal data of Europeans in the US, new investment is poised to flow into data centres here

With a government spending review looming, the research lobby is out to make the case for protecting the R&D budget. Here, Hayaatun Sillem of the Royal Academy of Engineering argues an increase in public R&D will pull in more private investment

The new money will fund basic research that would not attract grants from other sources

Draft work plans for 2016 and 2017 are out, with ambitions to replace animal testing, resist the rising tide of antimicrobial resistance and deliver faster internet speeds

The Commission is dovetailing its political and policy priorities into the new Horizon 2020 research plans for 2016 - 2017

Clever intellectual property (IP) management and carefully designed government policies can help SMEs raise more finance, reducing the risk for banks and venture capital investors, according to new Science|Business reports

Financial services chief reveals an assortment of 33 measures aimed at overcoming Europe’s investment crunch

ETH Zurich continues its fine rise across all major league tables, while US universities fall down a bit

Brexit would cut research funding and undermine the UK’s standing in science. But more than the money, EU collaboration is needed to address global problems like climate change and ageing, says Cambridge vice chancellor Leszek Borysiewicz

Research lobbyists gathered in Brussels to tell the European Commission what they like and what is niggling them about the €77B research programme to date

Lopsided trade talks serve US interests, says trade minister, as hopes fade of reaching an outline agreement by the end of 2015

The London Project to Cure Blindness reported completion of the first procedure to implant a patch seeded with retinal cells derived from an embryo. The treatment is for macular degeneration, a leading cause of vision loss

One of the best features of Horizon 2020 risks becoming its fatal flaw. Open-ended competitions have resulted in a flood of doomed applications, some 80 pages in length. Proposals should be shorter, and call topics tightened

A new Science|Business analysis puts the spotlight on the most innovative clusters in Europe, uncovering what it takes to translate research from bench to bedside and highlighting the crucial need for policy support, innovation pull, and access to finance